Literature DB >> 29035842

Derivation and characterization of integration-free iPSC line ISRM-UM51 derived from SIX2-positive renal cells isolated from urine of an African male expressing the CYP2D6 *4/*17 variant which confers intermediate drug metabolizing activity.

Martina Bohndorf1, Audrey Ncube1, Lucas-Sebastian Spitzhorn1, Jürgen Enczmann2, Wasco Wruck1, James Adjaye3.   

Abstract

SIX2-positive renal cells isolated from urine from a 51year old male of African origin bearing the CYP2D6 *4/*17 variant were reprogrammed by nucleofection of a combination of two episomal-based plasmids omitting pathway (TGFβ, MEK and GSK3β) inhibition. The induced pluripotent stem cells (iPSCs) were characterized by immunocytochemistry, embryoid body formation, DNA-fingerprinting and karyotype analysis. Comparative transcriptome analyses with human embryonic stem cell lines H1 and H9 revealed a Pearson correlation of 0.9243 and 0.9619 respectively.
Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29035842     DOI: 10.1016/j.scr.2017.10.004

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  9 in total

Review 1.  Pluripotent stem cells: induction and self-renewal.

Authors:  R Abu-Dawud; N Graffmann; S Ferber; W Wruck; J Adjaye
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-07-05       Impact factor: 6.237

2.  Constructing an Isogenic 3D Human Nephrogenic Progenitor Cell Model Composed of Endothelial, Mesenchymal, and SIX2-Positive Renal Progenitor Cells.

Authors:  Lisa Nguyen; Lucas-Sebastian Spitzhorn; James Adjaye
Journal:  Stem Cells Int       Date:  2019-05-02       Impact factor: 5.443

3.  Episomal Induced Pluripotent Stem Cells: Functional and Potential Therapeutic Applications.

Authors:  Aline Yen Ling Wang; Charles Yuen Yung Loh
Journal:  Cell Transplant       Date:  2019-11-14       Impact factor: 4.064

4.  Impaired p53-Mediated DNA Damage Response Contributes to Microcephaly in Nijmegen Breakage Syndrome Patient-Derived Cerebral Organoids.

Authors:  Soraia Martins; Lars Erichsen; Angeliki Datsi; Wasco Wruck; Wolfgang Goering; Eleftheria Chatzantonaki; Vanessa Cristina Meira de Amorim; Andrea Rossi; Krystyna H Chrzanowska; James Adjaye
Journal:  Cells       Date:  2022-02-25       Impact factor: 6.600

5.  The Nephrotoxin Puromycin Aminonucleoside Induces Injury in Kidney Organoids Differentiated from Induced Pluripotent Stem Cells.

Authors:  Lisa Nguyen; Wasco Wruck; Lars Erichsen; Nina Graffmann; James Adjaye
Journal:  Cells       Date:  2022-02-11       Impact factor: 7.666

Review 6.  Bilirubin-Induced Neurological Damage: Current and Emerging iPSC-Derived Brain Organoid Models.

Authors:  Abida Islam Pranty; Sara Shumka; James Adjaye
Journal:  Cells       Date:  2022-08-25       Impact factor: 7.666

7.  The presence of human mesenchymal stem cells of renal origin in amniotic fluid increases with gestational time.

Authors:  Md Shaifur Rahman; Lucas-Sebastian Spitzhorn; Wasco Wruck; Carsten Hagenbeck; Percy Balan; Nina Graffmann; Martina Bohndorf; Audrey Ncube; Pascale V Guillot; Tanja Fehm; James Adjaye
Journal:  Stem Cell Res Ther       Date:  2018-04-25       Impact factor: 6.832

8.  Human iPSC-derived iMSCs improve bone regeneration in mini-pigs.

Authors:  Pascal Jungbluth; Lucas-Sebastian Spitzhorn; Jan Grassmann; Stephan Tanner; David Latz; Md Shaifur Rahman; Martina Bohndorf; Wasco Wruck; Martin Sager; Vera Grotheer; Patric Kröpil; Mohssen Hakimi; Joachim Windolf; Johannes Schneppendahl; James Adjaye
Journal:  Bone Res       Date:  2019-10-24       Impact factor: 13.567

9.  The FGF, TGFβ and WNT axis Modulate Self-renewal of Human SIX2+ Urine Derived Renal Progenitor Cells.

Authors:  Md Shaifur Rahman; Wasco Wruck; Lucas-Sebastian Spitzhorn; Lisa Nguyen; Martina Bohndorf; Soraia Martins; Fatima Asar; Audrey Ncube; Lars Erichsen; Nina Graffmann; James Adjaye
Journal:  Sci Rep       Date:  2020-01-20       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.